COVID-19 in pediatric nephrology centers in Turkey

Simple item page
dc.contributor.authorLeventoğlu E.
dc.contributor.authorAtikel Y.Ö.
dc.contributor.authorNalçacioğlu H.
dc.contributor.authorDursun I.
dc.contributor.authorDursun H.
dc.contributor.authorYildirim Z.Y.
dc.contributor.authorYildiz N.
dc.contributor.authorAksoy G.K.
dc.contributor.authorTaşdemir M.
dc.contributor.authorÇelakil M.
dc.contributor.authorKiliç B.D.
dc.contributor.authorSelçuk Ş.Z.
dc.contributor.authorCanpolat N.
dc.contributor.authorÇakici E.K.
dc.contributor.authorÖzlü S.G.
dc.contributor.authorTülpar S.
dc.contributor.authorYüksel S.
dc.contributor.authorAtmiş B.
dc.contributor.authorDöven S.S.
dc.contributor.authorTaner S.
dc.contributor.authorErtan P.
dc.contributor.authorKavaz A.
dc.contributor.authorBayram M.T.
dc.contributor.authorKalyoncu M.
dc.contributor.authorGülleroğlu K.
dc.contributor.authorKabasakal C.
dc.contributor.authorDemir B.K.
dc.contributor.authorÇiçek R.Y.
dc.contributor.authorBilge I.
dc.contributor.authorDönmez O.
dc.contributor.authorKara A.
dc.contributor.authorYavaşcan Ö.
dc.contributor.authorÖzçelik G.
dc.contributor.authorYildirim D.G.
dc.contributor.authorGüler M.A.
dc.contributor.authorSönmez F.
dc.contributor.authorPoyrazoğlu H.
dc.contributor.authorAkman S.
dc.contributor.authorTopaloğlu R.
dc.contributor.authorAlpay H.
dc.contributor.authorBakkaloğlu S.A.
dc.date.accessioned2024-07-22T08:04:57Z
dc.date.available2024-07-22T08:04:57Z
dc.date.issued2022
dc.description.abstractBackground/aim: There is limited data on COVID-19 disease in children with kidney disease. We aimed to investigate the characteristics and prognosis of COVID-19 in pediatric nephrology patients in Turkey. Materials and methods: This was a national, multicenter, retrospective cohort study based on an online survey evaluating the data between 11th March 2020 and 11th March 2021 as an initial step of a detailed pediatric nephrology COVID-19 registry. Results: Two hundred and three patients (89 girls and 114 boys) were diagnosed with COVID-19. One-third of these patients (36.9%) were between 10–15 years old. Half of the patients were on kidney replacement therapy: kidney transplant (KTx) recipients (n = 56, 27.5%), patients receiving chronic hemodialysis (n = 33, 16.3%) and those on peritoneal dialysis (PD) (n = 18, 8.9%). Fifty-four (26.6%) children were asymptomatic. Eighty-two (40.3%) patients were hospitalized and 23 (28%) needed intensive care unit admission. Fifty-five percent of the patients were not treated, while the remaining was given favipiravir (20.7%), steroid (16.3%), and hydroxychloroquine (11.3%). Acute kidney injury developed in 19.5% of hospitalized patients. Five (2.4%) had MIS-C. Eighty-three percent of the patients were discharged without any apparent sequelae, while 7 (3.4%) died. One hundred and eight health care staff were infected during the study period. Conclusion: COVID-19 was most commonly seen in patients who underwent KTx and received HD. The combined immunosuppressive therapy and frequent exposure to the hospital setting may increase these patients’ susceptibility. Staff infections before vaccination era were alarming, various precautions should be taken for infection control, particularly optimal vaccination coverage. © TÜBİTAK.
dc.identifier.DOI-ID10.55730/1300-0144.5521
dc.identifier.issn13000144
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/12913
dc.language.isoEnglish
dc.publisherTurkiye Klinikleri
dc.rightsAll Open Access; Bronze Open Access
dc.subjectAdolescent
dc.subjectChild
dc.subjectCOVID-19
dc.subjectFemale
dc.subjectHumans
dc.subjectMale
dc.subjectNephrology
dc.subjectRetrospective Studies
dc.subjectTurkey
dc.subjectfavipiravir
dc.subjecthydroxychloroquine
dc.subjectimmunoglobulin
dc.subjectlow molecular weight heparin
dc.subjectsteroid
dc.subjectacute kidney failure
dc.subjectadolescent
dc.subjectadult
dc.subjectageusia
dc.subjectanosmia
dc.subjectArticle
dc.subjectcardiovascular disease
dc.subjectcohort analysis
dc.subjectcontrolled study
dc.subjectcoronavirus disease 2019
dc.subjectdisease exacerbation
dc.subjectdyspnea
dc.subjectend stage renal disease
dc.subjectfatigue
dc.subjectfemale
dc.subjectfever
dc.subjectglomerulopathy
dc.subjectgrowth retardation
dc.subjectheadache
dc.subjectheart arrest
dc.subjecthuman
dc.subjecthypertension
dc.subjectinfant
dc.subjectintensive care unit
dc.subjectkidney transplantation
dc.subjectlength of stay
dc.subjectmajor clinical study
dc.subjectmale
dc.subjectmulticenter study
dc.subjectmyalgia
dc.subjectnephrology
dc.subjectnewborn
dc.subjectobesity
dc.subjectpediatrics
dc.subjectperitoneal dialysis
dc.subjectpneumonia
dc.subjectpreschool child
dc.subjectquestionnaire
dc.subjectrenal replacement therapy
dc.subjectretrospective study
dc.subjectreverse transcription polymerase chain reaction
dc.subjectschool child
dc.subjecttomography
dc.subjecturinary tract disease
dc.subjectvaccination
dc.subjectyoung adult
dc.subjectchild
dc.subjectclinical trial
dc.subjectepidemiology
dc.subjecttherapy
dc.subjectturkey (bird)
dc.titleCOVID-19 in pediatric nephrology centers in Turkey
dc.typeArticle

Files

Collections

Scopus Koleksiyonu